J7401 — Mometasone furoate sinus implant, 10 micrograms
J7401 is a HCPCS Level II code for mometasone furoate sinus implant, 10 micrograms. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on March 31, 2021 and is not valid on new claims.
This code has been terminated
CMS terminated J7401 on March 31, 2021. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J7401
- Long descriptor
- Mometasone furoate sinus implant, 10 micrograms
- Short descriptor
- Mometasone furoate sinus imp
- Added
- October 1, 2019
- Terminated
- March 31, 2021
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J7401
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7401 is not quite right, the correct code is very often within a few positions of it.
- J7342Instillation, ciprofloxacin otic suspension, 6 mg
- J7345Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
- J7351Injection, bimatoprost, intracameral implant, 1 microgram
- J7352Afamelanotide implant, 1 mg
- J7353Anacaulase-bcdb, 8.8% gel, 1 gram
- J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
- J7355Injection, travoprost, intracameral implant, 1 microgram
- J7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg
- J7402Mometasone furoate sinus implant, (sinuva), 10 micrograms
- J7500Azathioprine, oral, 50 mg
- J7501Azathioprine, parenteral, 100 mg
- J7502Cyclosporine, oral, 100 mg
- J7503Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505Muromonab-cd3, parenteral, 5 mgterminated
- J7506Prednisone, oral, per 5 mgterminated
Questions about J7401
What is HCPCS code J7401?
J7401 is a HCPCS Level II code for mometasone furoate sinus implant, 10 micrograms. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J7401?
The CMS HCPCS file marks J7401 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J7401 still valid?
No. J7401 was terminated on March 31, 2021 and should not be used on new claims.